Genetic roadmap offers new hope for kids with tough cancers
NCT ID NCT02613962
First seen Apr 07, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study looked at tumors from 791 children and teens whose cancers had returned or did not respond to standard treatments. Researchers used advanced genetic testing to find specific changes in each tumor that could be targeted by existing drugs. The goal was to see if this personalized approach could help guide treatment decisions and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY PEDIATRIC TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto
Milan, 20133, Italy
-
Gustave Roussy
Villejuif, Val de Marne, 94805, France
-
Hospital Universitari Vall D'Hebron
Barcelona, Catalonia, 08035, Spain
-
Our Lady's Children's Hospital
Dublin, Crumlin, 12, Ireland
-
Schneider Children's Medical Center
Petah Tikva, 49202, Israel
Conditions
Explore the condition pages connected to this study.